Newer bulking agent offers durable results in SUI

San Diego-A newer bulking agent consisting of synthetic calcium hydroxylapatite compares favorably with traditional glutaraldehyde cross-linked bovine collagen as a treatment for type III stress urinary incontinence or intrinsic sphincteric deficiency, according to an interim analysis of data from an ongoing randomized trial of the two substances.

Related Content:

Drug TherapyFemale Urology

The antibiotic stigma associated with recurrent UTIs

Surgeons weigh in on MUS surgery for patients with stress urinary incontinence

Dr. Nickel discusses the safety of novel recurrent UTI vaccine